OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers such as Moderna and Amgen (Megan Morrone/Axios)
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- OpenAI launches GPT‑Rosalind, an AI model for life‑science research and drug discovery (per Axios).
- Moderna and Amgen are early preview customers testing the model on their pipelines (per Axios).
- GPT‑Rosalind is built to help researchers work faster, speeding up hypothesis generation and data analysis (per Axios).
Why it matters: Pharma firms like Moderna will use GPT‑Rosalind to speed up drug candidate identification, potentially cutting development time by months.
Ask SkimNews
